The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.
作者信息
Wallace Zachary S, Bhana Suleman, Hausmann Jonathan S, Robinson Philip C, Sufka Paul, Sirotich Emily, Yazdany Jinoos, Grainger Rebecca
机构信息
Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Rheumatologist, Crystal Run Health, Middletown, NY.
出版信息
Rheumatology (Oxford). 2020 Jun 1;59(6):1204-1206. doi: 10.1093/rheumatology/keaa191.
Abstract
摘要
相似文献
1
The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.
Rheumatology (Oxford). 2020 Jun 1;59(6):1204-1206. doi: 10.1093/rheumatology/keaa191.
2
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
Z Rheumatol. 2020 May;79(4):385-388. doi: 10.1007/s00393-020-00799-y.
3
How did COVID-19 pandemic changed the Portuguese rheumatology?
Acta Reumatol Port. 2020 Jun 8;45(Jan-Mar (1)):5-6.
4
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.
Ann Rheum Dis. 2020 Jun;79(6):840-842. doi: 10.1136/annrheumdis-2020-217628. Epub 2020 Apr 28.
5
Exploring the Impact of COVID-19 in Latin America.
J Clin Rheumatol. 2020 Sep;26(6):218-219. doi: 10.1097/RHU.0000000000001523.
6
#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic.
Rheumatol Int. 2020 Dec;40(12):2031-2037. doi: 10.1007/s00296-020-04710-5. Epub 2020 Sep 29.
7
COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
Clin Exp Rheumatol. 2020 Jul-Aug;38(4):748-753. Epub 2020 Jul 28.
8
Rheumatology in a time of Coronavirus: lessons from our early experiences.
QJM. 2020 Oct 1;113(10):715-716. doi: 10.1093/qjmed/hcaa163.
9
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.
Nat Rev Rheumatol. 2020 Jun;16(6):293-294. doi: 10.1038/s41584-020-0418-0.
10
Greetings from the editor.
Ann Rheum Dis. 2020 Jun;79(6):677-678. doi: 10.1136/annrheumdis-2020-217811.
引用本文的文献
1
Internet-based enrollment of a myositis patient cohort-a national experience.
Clin Rheumatol. 2024 Oct;43(10):3157-3166. doi: 10.1007/s10067-024-07091-3. Epub 2024 Aug 26.
2
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review.
Curr Rheumatol Rep. 2023 Nov;25(11):236-245. doi: 10.1007/s11926-023-01111-y. Epub 2023 Aug 19.
3
Social Media for Research Discourse, Dissemination, and Collaboration in Rheumatology.
Rheumatol Immunol Res. 2022 Dec 31;3(4):169-179. doi: 10.2478/rir-2022-0031. eCollection 2022 Dec.
4
Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review.
Bionanoscience. 2022;12(4):1436-1454. doi: 10.1007/s12668-022-00997-9. Epub 2022 Jun 15.
5
COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
Int J Rheum Dis. 2022 Jul;25(7):743-754. doi: 10.1111/1756-185X.14332. Epub 2022 May 11.
6
The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey.
Rheumatol Adv Pract. 2022 Feb 21;6(1):rkac001. doi: 10.1093/rap/rkac001. eCollection 2022.
7
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
RMD Open. 2022 Apr;8(1). doi: 10.1136/rmdopen-2021-002187.
8
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.
Nat Rev Rheumatol. 2022 Apr;18(4):191-204. doi: 10.1038/s41584-022-00755-x. Epub 2022 Feb 25.
9
Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees.
ACR Open Rheumatol. 2022 Feb;4(2):128-133. doi: 10.1002/acr2.11355. Epub 2021 Nov 17.
10
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639.
本文引用的文献
1
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.
N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23.
2
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
3
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
4
Covid-19 - Navigating the Uncharted.
N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28.
5
An interactive web-based dashboard to track COVID-19 in real time.
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
Zotero 插件